Zhejiang, China

Binbin Hong

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Hangzhou Rex Pharmaceutical Co., Ltd., Suzhou Sinovent Pharmaceuticals Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Binbin Hong. Retrieved from https://idiyas.com/inventor/binbin-hong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 9.6

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Binbin Hong: A Glimpse into His Patents and Contributions

Introduction

Binbin Hong is a prominent inventor based in Zhejiang, China, known for his groundbreaking contributions to the field of pharmaceuticals. With a total of two patents to his name, he has made significant strides in developing innovative compounds designed to tackle complex medical challenges.

Latest Patents

Hong's most recent inventions include a five-membered heterocyclic amide WNT pathway inhibitor and a benzofuran pyrazole amine kinase inhibitor. The first patent showcases a five-membered heterocyclic amide that acts as a WNT pathway inhibitor exhibiting remarkable anti-tumor activity. This inhibitor has been crafted through a target-based rational drug design approach, positioning it as a promising candidate for the next generation of WNT pathway inhibitors, with substantial clinical application value and market potential.

His second patent, the benzofuran pyrazole amine kinase inhibitor, introduces a compound aimed at regulating protein kinase activity to treat or prevent diseases related to protein kinases. Specifically, this invention addresses the anaplastic lymphoma kinase (ALK) and provides a methodological framework for preparing the compound. Importantly, this inhibitor has the potential to overcome the drug resistance associated with earlier generations of ALK inhibitors, marking a significant advancement in therapeutic options.

Career Highlights

Throughout his career, Binbin Hong has worked with reputable organizations such as Suzhou Sinovent Pharmaceuticals Co., Ltd. and Hangzhou Rex Pharmaceutical Co., Ltd. His experience in these companies has been pivotal in shaping his research and innovation trajectory, allowing him to apply his expertise in various pharmaceutical applications.

Collaborations

Hong has collaborated with notable colleagues in the field, including Yonghui Wang and Juan Zhou. These collaborations have undoubtedly enriched his research endeavors and contributed to the successful development of his patented innovations.

Conclusion

In summary, Binbin Hong's contributions to the pharmaceutical field through his innovative patents highlight his role as a key inventor in the industry. His work has the potential to influence treatment options significantly, particularly in overcoming drug resistance in challenging diseases, and exemplifies the spirit of innovation that drives progress in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…